Virtu Financial LLC Talaris Therapeutics, Inc. Transaction History

Virtu Financial LLC

  • $1.82 Billion
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 15, 2023
BUY
$0.94 - $1.64 $15,389 - $26,850
16,372 New
16,372 $17,000
Q2 2022

Aug 09, 2022
BUY
$4.51 - $9.85 $55,919 - $122,130
12,399 New
12,399 $56,000

Others Institutions Holding TALS

# of Institutions
3
Shares Held
75.7K
Call Options Held
0
Put Options Held
0
View Full List

About Talaris Therapeutics, Inc.

TALS Quotes by TradingView
  • Ticker TALS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,995,900
  • Market Cap $109M
  • Description
  • Talaris Therapeutics, Inc. operates as a late-clinical stage cell therapy company in the United States. The company engages in developing a method of allogeneic hematopoietic stem cell transplantation to transform the standard of care in solid organ transplantation and severe autoimmune diseases, as well as severe non-malignant blood, immune, an...
More about TALS
Track This Portfolio

Track Virtu Financial LLC Portfolio

Follow Virtu Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtu Financial LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email